Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lotus Ventures Inc C.J

Alternate Symbol(s):  LTTSF

Lotus Ventures Inc. is a Canada-based licensed cannabis producer and owner of the Lotus Cannabis Co. brand. The Company primarily cultivates cannabis flowers, which are sold in the wholesale, recreational, and medical markets across Canada. The Company owns and operates a 22,500 square foot indoor cannabis production facility in Armstrong, British Columbia and holds the licenses for cultivation and sale of cannabis in Canada. It has grown several cultivars, including the Keylime Kush, Black Blossom, Tranquil Elephantizer, and Kalifornia. Its Keylime Kush recreational portfolio includes 3.5 gram flower, 14 gram flower, and 3 x 0.5 gram pre-rolls. The Company sells its flagship product, the Keylime Kush, to over 300 retail stores across British Columbia and Ontario.


CSE:J - Post by User

Post by undervalueon Feb 22, 2023 10:25pm
175 Views
Post# 35299885

Yep, just about a $5 million loss

Yep, just about a $5 million lossWords cannot capture how big this hit is. 
Combine this with no doubt further cash burn, the debt structure, and the gst liability, shareholders, you are screwed. Completely. 



During the three months ended August 31, 2022 the Company recognized a net loss of $4,930,606, compared net income of $42,625 for the three months ended August 31, 2021. Net income for the three months ended August 31, 2022 decreased by $4,962,812 as a result of the decline in sales and gross margin, and impairment of inventory in the current period as compared to the prior comparative period. Significant items making up the change for the three months ended August 31, 2022 as compared to the three months ended August 31, 2021 were as follows: • Gross margin before fair value adjustments decreased by $838,566 as a result of the decrease in sales and impairment of inventory. • Impairment of $1,437,000 in harvested cannabis inventory recognized due to the capitalized costs exceeding the estimated net realizable value of that inventory in the three months ended August 31, 2022. • Loss for changes in fair market value of biological assets increased by $2,455,985 due to decline in the market prices. • Bank fees and interest increased by $122,597 as a result of increase in interest on outstanding loans received.
<< Previous
Bullboard Posts
Next >>